Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
Provided By GlobeNewswire
Last update: Aug 5, 2025
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
Read more at globenewswire.comNASDAQ:MDXH (12/5/2025, 3:52:38 PM)
3.65
+0.01 (+0.27%)
Find more stocks in the Stock Screener
